Biotech Momentum Picks Up: CRSP MRK XBI…Updates 10/29,31.
Update 10/30 1:45 pm EDT Markets weak on China deal, PMI data Sold CRSP at $50.with 25% gain in 2 weeks; will get back in on weakness. XBI off 0.89%, IBB down 0.85%, NAZ off 0.44%. BMY up 1.5% near 52 week highs. Teledoc (TDOC) a top 2019 small cap pick up over 12% on earnings-revenues up 24%....
Biotech Snapshot on a Lackluster Day-ALXN, BMRN…Update-10/25
Update-1 10/25 at close...A Good Day on Low Volume-NASDAQ up 0.7%, S&P is up 20.56% YTD! Large caps mixed with IBB down a tad 0.29%;leaders are BIIB,BMY,RHHBY NASDAQ-100 at record high; QQQ up 0.8% to $195.64. Gilead Sciences (GILD) a big loser on earnings miss down 4.25%. Revenue flat. XBI...
Bullish Trends in Biotech Today-Rebalance Portfolio with Healthcare…Update-1 Biogen
Update-1 10/22. Some follow through in biotech rally but sold off mirroring the NASDAQ about 2p,Maybe BREXIT related but we'll see later this week after many earnings reports. Large caps have been leading and although the IBB was up 1.66% it sold off from $107 level $106. Biogen (BIIB) helped...
Surprisingly Strong Earnings Spark Healthcare Stocks : Time to Rebalance Your Portfolio…Update-1
Update-1 Large caps were mixed but our top picks are doing well: ABBV,BMY,MRK,RHHBY. But bad news from JNJ and BA may have curbed buyer's sentiment. United Health (UNH) off Mondays lows of $220 to $245. In summary it looks like a good time fo adding larger cap healthcare weighting. Roche...
Biotech Stocks Mired in Uncertainty: China Deal, Drug Pricing Politics and Earnings Outlook…Update-2 Rally Day
Update-2 10/13...Biotech IPOs Remain Weak-Recent rally was weak for small cap biotechs Vir Biotechnology (VIR): A clinical stage immunology and infectious disease Company focused on new therapies for hepatitis (HBV), Influenza A, HIV and TB went public on Friday. Despite aa broad experienced...